Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Other Accumulated Expenses (2020 - 2025)

Bon Natural Life (BON) has disclosed Other Accumulated Expenses for 5 consecutive years, with $244871.0 as the latest value for Q3 2024.

  • On a quarterly basis, Other Accumulated Expenses fell 88.56% to $244871.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $244871.0, a 88.56% decrease, with the full-year FY2024 number at $244871.0, down 88.56% from a year prior.
  • Other Accumulated Expenses was $244871.0 for Q3 2024 at Bon Natural Life, down from $2.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.1 million in Q3 2023 to a low of $41711.0 in Q3 2021.
  • A 5-year average of $519703.4 and a median of $114431.0 in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: soared 1770.91% in 2023, then crashed 88.56% in 2024.
  • Bon Natural Life's Other Accumulated Expenses stood at $56604.0 in 2020, then decreased by 26.31% to $41711.0 in 2021, then soared by 174.34% to $114431.0 in 2022, then skyrocketed by 1770.91% to $2.1 million in 2023, then plummeted by 88.56% to $244871.0 in 2024.
  • Per Business Quant, the three most recent readings for BON's Other Accumulated Expenses are $244871.0 (Q3 2024), $2.1 million (Q3 2023), and $114431.0 (Q3 2022).